Lois Chandler
Chief Operating Officer chez GENE BIOTHERAPEUTICS, INC.
Profil
Lois A.
Chandler is currently the Chief Operating Officer at Taxus Cardium Pharmaceuticals Group, Inc. She previously worked as the Vice President-Product Development at Activation Therapeutics, Inc. from 2006 to 2019.
Dr. Chandler completed her undergraduate degree at Stanford University and holds a doctorate from the University of Southern California.
Postes actifs de Lois Chandler
| Sociétés | Poste | Début |
|---|---|---|
| GENE BIOTHERAPEUTICS, INC. | Chief Operating Officer | 01/07/2019 |
Anciens postes connus de Lois Chandler
| Sociétés | Poste | Fin |
|---|---|---|
Activation Therapeutics, Inc.
 Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Taxus Cardium Pharmaceuticals Group, Inc., Activation Therapeutics, Inc. develops late-stage clinical and commercial development of regenerative medicine therapeutics. | Corporate Officer/Principal | 01/01/2019 |
Formation de Lois Chandler
| Stanford University | Undergraduate Degree |
| University of Southern California | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENE BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Activation Therapeutics, Inc.
Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Taxus Cardium Pharmaceuticals Group, Inc., Activation Therapeutics, Inc. develops late-stage clinical and commercial development of regenerative medicine therapeutics. | Health Technology |
